CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking

Even in the “highly unlikely event” that the FDA does make CBD supplements legal, it will not do so retroactively, according to plaintiffs against CV Sciences in California’s Central District. However, the federal court, which also is hearing a similar case against competitor Charlotte’s Web, is not convinced.

Class Action Lawsuit Documents Envelope 3d Illustration

California’s Central District refused on 3 December to restart proceedings in a proposed consumer class action against CV Sciences, Inc. concerning the legality of its cannabidiol-infused dietary supplements.

The court maintains that opportunity should be afforded for the US Food and Drug Administration to issue anticipated rulemaking on...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America